StonvexLoading…
StonvexCore line items from BDN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $484.45M | $505.52M | $514.65M | $506.10M |
Operating Income | $26.66M | $54.88M | $-21.58M | $119.73M |
Net Income | $-178.25M | $-195.91M | $-196.79M | $53.82M |
EPS (Diluted) | $-1.03 | $-1.14 | $-1.15 | $0.31 |
Total Assets | $3.59B | $3.49B | $3.73B | $3.87B |
Total Liabilities | $2.79B | $2.45B | $2.41B | $2.24B |
Cash & Equivalents | $32.28M | $90.23M | $58.32M | $17.55M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 173.70M | 172.67M | 171.96M | 172.33M |